Author:
Sangaré Mohamed N’dongo,Baril Jean-Guy,de Pokomandy Alexandra,Laprise Claudie,Deshaies Catherine,Klein Marina,Thomas Réjean,Tremblay Cécile,Roger Michel,Pexos Costa,Greenwald Zoe,Machouf Nima,Durand Madeleine,Hardy Isabelle,Dakouo Mamadou,Laporte Louise,Trottier Helen
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference22 articles.
1. Dolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIV;Kandel;Drug Design Development and Therapy,2015
2. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial;Lennox;Lancet,2009
3. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection;Cooper;N Engl J Med,2008
4. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection;Martinez;N Engl J Med,2003
5. Outcome of 2 simplification strategies for the treatment of human immunodeficiency virus type 1 infection;Maggiolo;Clin Infect Dis,2003
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献